Treatment for primary infection.
Smart
T
T
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D018849:Controlled Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir; D019259:Lamivudine; D010919:Placebos; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use; D019438:Ritonavir; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use; D014633:Valine / Q000008:administration & dosage / Q000627:therapeutic use; D016047:Zalcitabine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D010919:Placebos; D011725:Pyridines; D013844:Thiazoles; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016047:Zalcitabine; D014633:Valine; D019438:Ritonavir